Table 1.
| |||
---|---|---|---|
Compound | R | Inhibition % @ 10 μM | Viability % @ 10 μM |
8a | 7 | 85 | |
9a | 51 | 100 | |
8b | 0 | 99 | |
9b | 17 | 90 | |
8c | 5 | 100 | |
9c | 42 | 93 | |
8d | 0 | 100 | |
9d | 88 | 95 | |
8e | 0 | 100 | |
9e | 57 | 100 | |
8f | 0 | 100 | |
9f | 10 | 99 | |
8g | H | 5 | 100 |
9g | 0 | 100 |
| |||
---|---|---|---|
Compound | R | Inhibition % @ 10 μM | Viability % @ 10 μM |
8a | 7 | 85 | |
9a | 51 | 100 | |
8b | 0 | 99 | |
9b | 17 | 90 | |
8c | 5 | 100 | |
9c | 42 | 93 | |
8d | 0 | 100 | |
9d | 88 | 95 | |
8e | 0 | 100 | |
9e | 57 | 100 | |
8f | 0 | 100 | |
9f | 10 | 99 | |
8g | H | 5 | 100 |
9g | 0 | 100 |